Loading provider…
Loading provider…
Endocrinology, Diabetes & Metabolism Physician in Sacramento, CA
NPI: 1003089871Primary Practice Location
Mercy Medical Group, a Service of Dignity Health Medical Foundation
3000 Q St, Sacramento, CA
Primary Employer
Mercy Medical Group, a Service of Dignity Health Medical Foundation
dignityhealth.org
HQ Phone
Get MD Patrick's Phone NumberMobile
Get MD Patrick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2006 - 2026

American Board of Internal Medicine
Endocrinology, Diabetes and Metabolism

American Board of Internal Medicine
Internal Medicine
Drexel University College Of Medicine
drexel.edu
Medical School
Until 2004
Los Angeles County-Harbor-UCLA Medical Center
Fellowship • Endocrinology
2008 - 2010
Residency • Internal Medicine
2004 - 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 395 | 839 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 151 | 151 |
| 3 | 95251Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | 147 | 377 |
| 4 | 83036Hemoglobin A1C level | 77 | 96 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 76 | 95 |
Characterization of the anaemia associated with Graves’ disease
Authors: Andrew Gianoukakis, Yutaka Niihara, Paul Fu
Authors: Andrew Gianoukakis, Marelle Yehuda, Shelly Gupta, Sarah Tomassetti, Shelly Gupta
Journal: Am J Blood Res
Publication Date: 2021-06-15
'Thymic Hyperplasia Associated with Graves'' Disease: Pathophysiology and Proposed
Authors: Uzma Haider
Publication Date: 2017-08
Lead Sponsor: Boehringer Ingelheim
Intervention / Treatment: DRUG: Brigimadlin
Lead Sponsor: Ain Shams University
Intervention / Treatment: DIAGNOSTIC_TEST: ultrasound detection of body composition
Lead Sponsor: Intercept Pharmaceuticals
Intervention / Treatment: DRUG: Matching Placebo, DRUG: OCA